Normal view MARC view ISBD view

[Neuromodulation--controlled analgesia. Criteria for long efficiency]. [electronic resource]

By:

Isagulian, E D

Contributor(s):

Shabalov, V A

Producer: 20081027Description: 18-26; discussion 26-8 p. digitalISSN:

0042-8817

Subject(s):

In: Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko no. 2

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Case Reports; English Abstract; Journal Article

There are no comments on this title.

to post a comment.

Previous

Back to results

Next

1
2
3
4
5
6
7
8
9
10

1 Disruption of G protein-coupled receptor 39 impairs insulin secretion in vivo.
by Tremblay, Frédéric
2 Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice.
by Jouihan, Hani
3 Gut check on diabesity: leveraging gut mechanisms for the treatment of type 2 diabetes and obesity.
by Will, Sarah
4 A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice.
by Hornigold, David C
5 Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
by Boland, Michelle L
6 Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists.
by Erbe, David V
7 Loss of coiled-coil domain containing 80 negatively modulates glucose homeostasis in diet-induced obese mice.
by Tremblay, Frédéric
8 Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice.
by Boland, Brandon B
9 Activation of TrkB with TAM-163 results in opposite effects on body weight in rodents and non-human primates.
by Perreault, Mylène
10 Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent.
by Artis, Dean R

Close